Ossifying parosteal lipoma

Ossifying parosteal lipoma is a benign adipocytic neoplasm situated directly on the cortical bone surface beneath the periosteum, characterized by a juxtacortical mass of mature adipose tissue intimately associated with reactive osseous and/or chondroid changes in the adjacent bone.[1][2] The lesion is believed to arise through multidirectional mesenchymal modulation within the periosteum, whereby periosteal progenitor cells differentiate along adipocytic, chondroid, and osteoblastic lines.[2] The ossifying variant specifically denotes the presence of internal ossification within the lipomatous mass and/or bony excrescences projecting from the cortical surface.[2][3] The signature imaging pattern—a well-circumscribed fat-attenuation mass containing osseous protuberances continuous with the underlying cortex—is considered pathognomonic and may obviate biopsy when characteristic features are present.[1][4] Management is conservative excision when symptomatic.

• Parosteal lipoma is the preferred current term, classified among benign lipomatous lesions affecting bone in the WHO framework of soft tissue and bone tumours.[4][5]
• Ossifying parosteal lipoma specifies the variant containing internal ossification and/or osseous excrescences, corresponding to subtypes II–IV in the Miller–Ragsdale–Sweet classification.[2]
• Historical synonyms include periosteal lipoma and chondrolipoma of soft tissue; these terms are now largely obsolete but appear in older literature.[2]
• The lesion should be distinguished from osteolipoma (ossifying lipoma), a separate entity in which metaplastic bone forms within a soft-tissue lipoma independent of bone cortex.[6][7]

Parosteal lipoma is rare, comprising approximately 0.3% of all lipomas.[8] In the largest imaging series, the mean age at diagnosis was 57 years (range 31–80), with a roughly equal male-to-female ratio.[1] The vast majority arise along the diaphyses and metaphyses of long bones, most commonly the femur, followed by the radius/ulna and humerus.[1][4] Involvement of the jaws is exceedingly rare; only isolated case reports describe mandibular parosteal lipoma.[3] No familial or syndromic associations have been established.

Presentation and symptoms

• Most patients present with a slowly enlarging, painless soft-tissue mass that has been present for months to years.[9][10]
• Pain, when present, is typically mild and related to mass effect on adjacent structures rather than intrinsic aggressiveness.[9]
• In the jaws, the lesion may present as a firm, non-tender submandibular or buccal swelling with intact overlying mucosa.[3]

Complications and red flags

• Peripheral nerve compression is a recognized complication at appendicular sites, manifesting as motor weakness or sensory deficit; muscle atrophy in the distribution of the affected nerve may be evident on examination.[11]
• In the mandible, proximity to the inferior alveolar nerve raises the possibility of lip paresthesia, although this has not been consistently documented given the rarity of jaw involvement.[3]
• Rapid growth, fixation to deep structures, or pain disproportionate to size should prompt consideration of a malignant alternative and warrant biopsy.[7][9]

Location and distribution

• In the appendicular skeleton, parosteal lipomas characteristically arise along the diaphyseal or metaphyseal cortex of long bones.[1][4]
• Mandibular involvement is rare; the reported case demonstrated a mass along the lateral cortex of the mandibular body.[3]
• The lesion is always juxtacortical (parosteal), situated on the external bone surface beneath the periosteum, distinguishing it from intraosseous and intramuscular lipomas.[4]

Periphery and shape

• The soft-tissue (lipomatous) component is well circumscribed and lobulated, often with a thin capsule.[1][3]
• Margins are smooth and sharply defined against surrounding soft tissue, reflecting the benign nature of the mass.[9][11]

Internal architecture

The hallmark of the ossifying variant is a dual-component architecture: a dominant radiolucent fatty mass containing radiopaque osseous elements.

• Fatty component: On conventional radiographs, the lipomatous portion appears as a well-defined radiolucent soft-tissue mass. On CT, it demonstrates homogeneous fat attenuation (approximately −60 to −120 HU), identical to subcutaneous fat. Thin internal septa may be present.[1][3][4]
• Osseous component: Bony excrescences project from the cortical surface into the fatty mass. These are commonly pedunculated (stalk-like), though a sessile (broad-based) morphology is also recognized. The excrescences contain mature trabecular bone; a subset also demonstrates radiating bone spicules extending into the lipomatous portion. Internal ossification within the fatty mass itself—distinct from the cortical excrescence—is characteristic of the ossifying variant and appears as irregular radiopaque foci or lamellae.[1][2][3]
• Non-lipomatous soft-tissue elements (fibrous tissue, myxoid change) are common within the fatty portion and may produce faint heterogeneity on cross-sectional imaging.[1]

Effects on adjacent structures

• Cortical thickening and periosteal reaction at the base of the osseous stalk are characteristic and present in the large majority of cases.[1][11]
• The osseous excrescence is firmly attached to the cortex but does not invade the medullary canal; continuity of the cortex is maintained.[1][4]
• Teeth: In the rare mandibular case, displacement of adjacent teeth or the mandibular canal may occur, but tooth resorption has not been described.[3]
• Nerve involvement: At appendicular sites, the mass may encase or compress adjacent nerves, producing denervation-pattern muscle atrophy visible on cross-sectional imaging.[11]

Growth pattern and cortical involvement

• Growth is slow and expansile, displacing rather than infiltrating surrounding soft tissues.[9][10]
• The cortex at the attachment site shows reactive hyperostosis but no cortical destruction or periosteal elevation suggestive of malignancy.[1][12]

Recognized variants (Miller–Ragsdale–Sweet classification)

Four morphologic subtypes have been described based on the degree of chondro-osseous modulation:[2]

• Type I — No ossification: pure fatty mass on the cortical surface without bony excrescence.
• Type II — Pedunculated exostosis: a stalk-like bony projection arising from the cortex, surrounded by the lipomatous mass.
• Type III — Sessile exostosis: a broad-based bony protuberance with overlying fat.
• Type IV — Patchy chondro-osseous modulation: irregular foci of cartilage and bone scattered within the lipomatous component.

Types II–IV constitute the "ossifying" variants. The pedunculated exostosis pattern (Type II) is the most commonly encountered morphology.[1][2]

CT

On medical CT, the lipomatous component demonstrates homogeneous fat attenuation (negative Hounsfield units), and the osseous excrescences and internal ossification are sharply delineated, making CT the most reliable modality for confirming the dual fat-plus-bone composition.[3][13] Branch-like bony protuberances continuous with the cortex are well demonstrated on axial and reformatted images.[3] CT is particularly valuable in the jaws, where the relationship of the mass to the mandibular cortex, teeth, and inferior alveolar canal can be precisely mapped.[3]

MRI

MRI confirms the lipomatous nature of the mass: the fatty component follows subcutaneous fat signal on all pulse sequences (high T1, high T2, signal dropout on fat-suppressed sequences).[4][11] The osseous excrescence appears as a signal-void structure continuous with the cortex. MRI is superior to CT for delineating the relationship of the mass to adjacent nerves and muscles, identifying denervation-pattern muscle atrophy, and detecting cartilaginous or fibrous tissue adjacent to larger excrescences.[11] These features are important for preoperative planning.

Nuclear medicine

Bone scintigraphy may show radiotracer uptake in the osseous excrescence, reflecting active bone turnover, while the lipomatous component is photopenic.[1] FDG PET/CT demonstrates no significant FDG uptake, consistent with benign biology and helping to exclude a metabolically active malignancy.[1]

The combination of a well-circumscribed juxtacortical fatty mass with an osseous excrescence continuous with the cortex is pathognomonic when all features are present. Diagnostic difficulty arises when the fatty component is not recognized on conventional radiographs or when the osseous component dominates the imaging appearance.

The highest-risk diagnostic pitfall is misinterpreting the osseous excrescence as a surface osteosarcoma or osteochondroma when the fatty component is not appreciated on conventional radiographs. Cross-sectional imaging with CT or MRI to confirm fat attenuation/signal within the mass resolves this ambiguity in virtually all cases and may obviate biopsy.[1][4]

Microscopic findings

• The lipomatous component consists of mature adipocytes without nuclear hyperchromasia, atypia, or lipoblasts, identical to conventional lipoma.[3][9]
• Thin fibrous septa traverse the adipose tissue and may contain small blood vessels.[9]
• The osseous component shows mature lamellar bone with or without a cartilaginous cap; enchondral ossification may be evident at the interface between cartilage and bone.[2][16]
• Cortical thickening and periosteal new bone formation are present at the attachment site.[1][2]

Variants and chondro-osseous modulation

Chondroid differentiation (hyaline cartilage) is common in the ossifying variants and corresponds to the cartilage cap seen over the excrescence or to patchy chondroid foci within the mass (Type IV).[2][16] This chondro-osseous modulation is believed to reflect the pluripotent differentiation capacity of periosteal mesenchymal cells rather than a neoplastic cartilaginous process.[2]

Radiologic-pathologic correlation

The pedunculated or sessile bony excrescence seen on imaging corresponds histologically to mature trabecular bone with or without a cartilage cap, while the surrounding radiolucent/fat-attenuation mass corresponds to lobules of mature adipose tissue.[1][2] Internal ossification foci within the fatty mass correlate with scattered islands of metaplastic lamellar bone.[3]

Key molecular distinction

Unlike atypical lipomatous tumor/well-differentiated liposarcoma, parosteal lipoma lacks MDM2 amplification on FISH testing.[7] When histologic concern for atypia arises—particularly in deep-seated or recurrent lesions—MDM2 FISH is the definitive discriminator.[7]

Workup and referral

• When characteristic imaging features are present (juxtacortical fat-attenuation mass with cortical excrescence), the diagnosis can be made with high confidence on CT or MRI, and biopsy may not be necessary.[1][4]
• Atypical features—thick enhancing septa, nodular non-adipose tissue, rapid growth—should prompt incisional biopsy or referral to a musculoskeletal oncology center.[7][9]
• In the jaws, referral to oral and maxillofacial surgery is appropriate for both diagnostic confirmation and definitive management.[3]

Definitive treatment

• Marginal excision is the treatment of choice for symptomatic lesions, including removal of the osseous excrescence from the cortical surface.[9][10][17]
• Asymptomatic lesions with pathognomonic imaging features may be observed with clinical and imaging follow-up.[1]
• In the mandible, surgical excision with preservation of the inferior alveolar nerve and adjacent vital structures is the goal.[3]

Recurrence and prognosis

• Parosteal lipoma is a benign neoplasm with no documented malignant potential.[1][8][9]
• Recurrence after marginal excision is exceedingly rare and has not been reported in the available literature.[9][10][17]
• Long-term prognosis is excellent; no cases of malignant transformation have been described.[1][6]